Allied World
Most physicians believe that their prescribing practices will not be investigated. However, a recent article published in the Annals of Internal Medicine highlights consideration of the evolving landscape of pain management with opioid analgesics by practitioners both treating and following patients complaining of chronic non-cancer pain. Taken in conjunction with the recently revised Federation of State Medical Boards (FSMB) Model Policy, physicians who treat patients with analgesic opioids may be more vulnerable than ever to medical malpractice litigation and licensing board actions.